ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Shalala Named President, University Of Miami.

November 24, 2000

Memantine Can Delay Onset Of Cognitive Function Decline

November 30, 2012

Radiotherapy Plus Cetuximab May Control Head/Neck Cancer

November 26, 2010

Outside Experts Might Lengthen NDA Approval, Peck Asserts

September 7, 1990

NCAB Votes Down Effort to Delay CCOP RFA, Directs Subcommittee To Look Again A Program Components

February 12, 1982

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

January 30, 1998